Increased renal glomerular endothelin-1 release in gentamicin-induced nephrotoxicity

Area of Science:

• Nephrology
• Pharmacology
• Molecular Biology

Background:

• Gentamicin nephrotoxicity impairs renal plasma flow and creatinine clearance.
• Endothelins (ET) are known potent renal vasoconstrictors.
• The specific role of ET-1 in gentamicin-induced renal failure requires elucidation.

Purpose of the Study:

• To investigate the involvement of endothelin-1 (ET-1) in the pathogenesis of gentamicin-induced acute renal failure (ARF).

Main Methods:

• Rats received gentamicin (100 mg/kg/day) for 2, 4, or 6 days.
• Renal function assessed via insulin, para-aminohippuric acid, and creatinine clearance.
• Glomerular ET-1 release and plasma ET-1 concentrations were measured using RIA.
• Histological examination evaluated tubular and glomerular structures.

Main Results:

• Gentamicin induced dose-dependent increases in plasma creatinine and decreases in creatinine clearance.
• Significant reductions in inulin and para-aminohippuric acid clearance were observed.
• Histology revealed marked tubular necrosis but no glomerular structural changes.
• Both plasma ET-1 levels and glomerular ET-1 release were elevated in gentamicin-treated rats.
• Direct addition of gentamicin to control glomeruli did not alter ET-1 production.

Conclusions:

• Elevated plasma ET-1 levels and increased glomerular ET-1 release are implicated in the reduced glomerular filtration rate seen in gentamicin-induced ARF.
• ET-1 may play a mediating role in gentamicin nephrotoxicity.
• These findings highlight ET-1 as a potential therapeutic target in preventing gentamicin-induced kidney injury.